Editorial [Vigabatrin: An Antiepileptic Drug with Major Benefits but Significant Adverse Effects]

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|5|3|188-189

ISSN： 1574-8863

Source： Current Drug Safety, Vol.5, Iss.3, 2010-07, pp. : 188-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Adverse Drug Reactions – Preventable or Unexpected?

By  

Current Drug Safety, Vol. 9, Iss. 1, 2014-03 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Adverse Effects, Adverse Events and Side-Effects: Does the Terminology Matter?

By  

Current Drug Safety, Vol. 6, Iss. 1, 2011-02 ,pp. : 1-2

Bentham Science Publishers

Access to resources Recommend Favorite

A systematic review of placebo‐controlled trials of topiramate: How useful is a multiple‐indications review for evaluating the adverse events of an antiepileptic drug?

By  

EPILEPSIA, Vol. 56, Iss. 12, 2015-12 ,pp. : 1910-1920

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ambulatory Care Visits for Treating Adverse Drug Effects in the United States, 1995–2001

By Zhan Chunliu   Arispe Irma   Kelley Edward   Ding Tina   Burt Catharine W.   Shinogle Judith   Stryer Daniel  

Joint Commission Journal on Quality and Patient Safety, Vol. 31, Iss. 7, 2005-07 ,pp. : 372-378

Joint Commission Resources

Access to resources Recommend Favorite

Antiepileptic drug behavioral side effects and baseline hyperactivity in children and adolescents with new onset epilepsy

By  

EPILEPSIA, Vol. 59, Iss. 1, 2018-01 ,pp. : 146-154

John Wiley & Sons Inc

Access to resources Recommend Favorite